About Technology Issues FAQ

Links

Mechanisms of Action of the KCa2-Negative Modulator AP30663, a Novel Compound in Development for Treatment of Atrial Fibrillation in Man

Mechanisms of Action of the KCa2-Negative Modulator AP30663, a Novel Compound in Development for Treatment of Atrial Fibrillation in Man — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.